COVID-19 Vaccine Provider Weekly Updates

Stay Safe MN logo

COVID-19 Vaccine Provider Weekly Updates

View this as a webpage

Minnesota Department of Health

July 21, 2022


CDC recommends Novavax COVID-19 vaccine

On July 19, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices (ACIP) recommendation for the use of Novavax COVID-19 vaccine for adults ages 18 and older under an emergency use authorization (EUA).   

  • The Novavax COVID-19 vaccine is authorized for emergency use as a two-dose (0.5mL) primary series in adults 18 years of age and older, given 3-8 weeks apart. 
  • Novavax comes in a 10 dose multi-dose vial, and once punctured needs to be used within 6 hours. 
  • The federal government has initially ordered just over 3 million doses, which is a smaller amount compared to other COVID-19 vaccines. States will receive allocations of Novavax vaccine based on their population. An announcement will be sent out when it is available to order in MIIC with further details.

Refer to CDC’s media statement CDC Recommends Novavax’s COVID-19 Vaccine for Adults and the EUA factsheets FDA: Novavax COVID-19 Vaccine, Adjuvanted for detailed vaccine information. 

CDC has updated their Interim Clinical Considerations for Use of COVID-19 Vaccines, and At-A-Glance COVID-19 Vaccination Schedule.  We are updating our MDH resources with this recent change and they will be posted on COVID-19 Vaccine Providers soon. 

MIIC COVID-19 assessment report

MIIC users can run a report to measure COVID-19 immunization coverage rates. This report is available for the user’s organization or for a specific group of clients. Knowing your organization’s coverage rates can help in vaccination planning and provide helpful context for determining your organization’s need for reminder/recall activities for COVID-19 vaccination.  

The MIIC COVID-19 assessment report can be generated for a range of patient ages, including down to age 6 months. Please review our user guide at Single Vaccine Assessment Report. Please contact the MIIC Help Desk at with any questions. 

Find previous bulletins at COVID-19 Vaccine Provider Updates.